Day One Biopharmaceuticals, Inc. ( DAWN) - Stock Earnings
Stock symbol DAWN is outdated, potentially delisted? Maybe it is available on other exchange?
DAWN Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q2 | -30.3 million USD | 33.9 million USD |
| 2025Q3 | -19.7 million USD | 39.8 million USD |
| 2025Q4 | -21.3 million USD | 53.7 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
DAWN Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -188.9 million USD | — USD |
| 2024 | -95.5 million USD | 131.2 million USD |
| 2025 | -107.3 million USD | 158.2 million USD |
| 2026 Est. | — | — |
DAWN
Price: $21.53
52 week price:
Earnings Per Share: -1.04 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 433900
Market Capitalization: 2.2 billion